MAPT and Alzheimer disease: Nevertheless, they are positive, as they indicate that DMSCs may be able to reverse the neurodegeneration and cognitive decline associated with AD by modifying neural differentiation, neuroinflammation, and neuronal apoptosis, as well as increasing amyloid plaque degradation while also inhibiting tau protein hyperphosphorylation.